DermBiont

DermBiont

Skin microbiome therapeutics platform to treat and prevent skin diseases.

HQ location
Cambridge, United States
Launch date
Employees
Enterprise value
$140m
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor

€0.0

round
N/A

€0.0

round
investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor investor investor

€0.0

Valuation: €0.0

round
*
N/A

$8.1m

Convertible
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by DermBiont

Edit
Chromaderm
ACQUISITION by DermBiont Dec 2021